Table 1. Relationship between TPD52 expression and clinicopathological features of patients with HCC (n = 154).
Clinicopathologic variables | Number | TPD52 expression | P value | |
---|---|---|---|---|
low | high | |||
All cases | 154 | 86 | 68 | |
Age (years) | 0.623 | |||
<50 | 89 | 51 | 38 | |
≥50 | 65 | 35 | 30 | |
Gender | 0.842 | |||
Male | 123 | 70 | 53 | |
Female | 31 | 16 | 15 | |
HBV | 0.325 | |||
Negative | 21 | 14 | 7 | |
Positive | 133 | 72 | 61 | |
Tumor size(cm) | 0.745 | |||
<5 | 77 | 42 | 35 | |
≥5 | 77 | 44 | 33 | |
Tumor number | 0.838 | |||
Single | 124 | 70 | 54 | |
Mutiple | 30 | 16 | 14 | |
Liver cirrhosis | 1.000 | |||
No | 33 | 19 | 14 | |
Yes | 121 | 67 | 54 | |
Tumor encapsulation | 0.662 | |||
None | 58 | 33 | 25 | |
Complete | 53 | 31 | 22 | |
Incomplete | 43 | 22 | 21 | |
Serum AFP | 0.245 | |||
<400 | 95 | 49 | 46 | |
≥400 | 59 | 37 | 22 | |
Histilogical differentiation | 0.178 | |||
Well | 52 | 26 | 26 | |
Moderate | 66 | 35 | 31 | |
Poor | 36 | 25 | 11 | |
TNM stage | 0.011* | |||
I-II | 100 | 48 | 52 | |
III | 54 | 38 | 16 |
AFP, alpha-fetoprotein.
Statistically significant (P < 0.05).